Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial

Introduction: Affecting ~1% of the world population, schizophrenia is known as one of the costliest and most burdensome diseases worldwide. Antipsychotic medications are the main treatment for schizophrenia to control psychotic symptoms and efficiently prevent new crises. However, due to poor compli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Jingmei, Huang, Jing, Long, Yujun, Wang, Xiaoyi, Wang, Ying, Yang, Ye, Hei, Gangrui, Sun, Mengxi, Zhao, Jin, Li, Li, Shao, Tiannan, Wang, Weiyan, Kang, Dongyu, Liu, Chenchen, Xie, Peng, Huang, Yuyan, Wu, Renrong, Zhao, Jingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947302/
https://www.ncbi.nlm.nih.gov/pubmed/33716817
http://dx.doi.org/10.3389/fpsyt.2021.611070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947302/
https://www.ncbi.nlm.nih.gov/pubmed/33716817
http://dx.doi.org/10.3389/fpsyt.2021.611070

Ejemplares similares